Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide.
-
Shell (LSE:SHEL) has agreed to sell its wholly owned subsidiary BG Cyprus, including its stake in the Aphrodite gas field, to MOL Group.
-
The deal marks a major exit from an upstream project in Cyprus and reshapes Shell's global portfolio focus.
-
MOL Group gains exposure to the Aphrodite gas development as Shell reduces involvement in this non operated asset.
For readers looking to explore more stocks tied to long term portfolio repositioning themes, a useful next step is 7 high quality undervalued stocks
Shell sits among the largest integrated oil and gas groups globally, with operations across upstream production, liquefied natural gas, refining and low carbon energy projects. The stock trades at about £32.805 and has delivered returns of 18.9% year to date and 25.0% over the past 12 months, with a gain over five years of 168.2%.
We've flagged 2 risks for Shell. See which could impact your investment.
How does selling Aphrodite fit Shell's LNG and upstream focus?
The Aphrodite sale moves Shell further toward high grading its portfolio. The company keeps exposure to liquefied natural gas through projects such as LNG Canada and ARC Resources while exiting a non operated position in Cyprus Offshore Block 12. For you as an investor, this means Shell is continuing to concentrate capital and management time on assets where it has more control, scale or trading advantages, rather than tying up resources in earlier stage or smaller upstream positions.
Does this deal change the current Shell Narrative?
The existing Narrative around Shell already highlights portfolio pruning in areas like chemicals, retail and renewables, with capital redirected toward deepwater and LNG. Selling BG Cyprus and the Aphrodite stake is consistent with that pattern rather than a break from it. The move sits alongside recent divestments and keeps the focus on LNG growth, operational efficiency and shareholder distributions, while leaving the company's exposure to oil and gas price risk and decarbonisation policy unchanged.
What should investors watch next for this Shell transaction?
The key signpost is completion of the deal, which is expected in early 2027 once regulatory approvals are in place. Until then, Aphrodite remains in Shell's reported portfolio. Investors can track whether future operating updates call out any production or reserve changes linked to Cyprus, and how proceeds are allocated between dividends, buybacks and funding for projects such as ARC Resources and LNG Canada.
For the full picture including more risks and rewards, check out the complete Shell analysis . Alternatively, you can check out the community page for Shell to see how other investors believe this latest news will impact the company's narrative.
Do you think there's more to the story for Shell? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SHEL.L .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
